Avantor chromatography experts are presenting research on stationary phase selectivity, biotherapeutic analysis, LC method development, and LC-MS/MS analysis at the ISC 2026 conference in Prague.
Published
Signal category
Presence & Recognition
Quote
“Hear from Avantor® chromatography experts presenting research on stationary phase selectivity, biotherapeutic analysis, LC method development and LC-MS/MS analysis.”
— Avantor team
Company
- Industry
- Biotechnology Research
- Location
- Radnor Township, US
- Company size
- 12,811 employees
Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor.